A National Coverage Survey was conducted between
August 2007 and April 2008 in all 33 provinces of Indonesia.
The coverage survey showed 91% coverage for BCG, 75% for DPT3, 83% for
OPV3, 74% for HepB3 and 80% for measles with wide ranges in the province
level. The result was included in
the latest WHO/UNICEF global estimation.
A technical advisory group (TAG) on immunization
was established in June 2007. The general objective of establishing a
functioning technical advisory body at the country level is to guide policy
makers and programme managers to enabled them to
make evidence-based decision on the choices that a country will face in the
future for new vaccines and technologies.
Technical Working Group (TWG) for Immunization
was established following the end of measles SIAs.
TWG is coordinated by WHO and is chaired by the National EPI Manage. TWG
meets minimum once a month with key technical partners to discuss, monitor
and advise the EPI manager on development, strengthening and implementation
of routine immunization programme in Indonesia to
achieve its national and global objectives and goals.
National Commission on Adverse Events Following
Immunization established an AEFI task force. Beside at national level, this
kind of task force is also formed at province level. Currently there are 32
provincial task forces on AEFI. A National AEFI meeting was conducted in
December 2008 with assistance from WHO. Provincial
training will take place in 2009.
A cold chain national inventory was done and analyzed. A cold chain
investment meeting as conducted with stake holders and partners to cover
the requirement in the coming years.
WHO supported Nation Wide Rapid Assessment of
Injection Safety started in 2008 and will be completed phase wise in